MedPath

Laser Closure of Anal Fistula (FiLaC)

Not Applicable
Conditions
Fistula in Ano
Anal Fistula
Sphincter Ani Incontinence
Registration Number
NCT04161469
Lead Sponsor
Surp Pırgiç Armenian Hospital
Brief Summary

Laser closure of the perianal fistula is the minimally invasive and low complication rate procedure which is a life-saving way for complex fistulas, preserving anal sphincter injury. Unfortunately, wide range success rate reported before (30-80%), the investigators are searching to reach better rates. Internal closure of the fistula orifice offered by some authors. The investigators are aimed to identify the efficiency of this.

Detailed Description

Despite the developments in the surgical field, the treatment of anal fistula is still a challenging problem, especially in complex, transsphincteric cases. The surgical treatment aims to avoid recurrences and also to preserve normal sphincter functions. The FiLaC procedure was recently reported non-invasive technique in perianal fistulas for treatment and preserving anal sphincter function with a good success rate. In 2018, one of our colleagues published a 40% complete healing rate by using only FiLaC technique in 103 consecutive perianal fistula patients (Prof. Cem Terzi). Some authors advocated that the closure of the internal orifice increasing the success rate. Therefore, the investigators decided to modify the surgical technique focusing closure of the internal opening associated with the FiLaC procedure.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • complex anal fistula
  • high anal fistulas
  • recurrent anal fistulas
Exclusion Criteria
  • superficial anal fistulas
  • multibranching anal fistulas

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from perianal fistula disease severity score at 6 months6th month after the surgery

0: no active disease or complete healing,

1. slight drainage with minimal symptoms,

2. persistent symptomatic drainage,

3. painful symptomatic drainage,

4. severe perianal disease potentially requiring diversion

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Surp Pırgic AH

🇹🇷

Istanbul, Zeytinburnu, Turkey

Surp Pırgic AH
🇹🇷Istanbul, Zeytinburnu, Turkey
Kursat R Serin, Ass. Prof.
Contact
00905322008163
dr_krserin@hotmail.com
Cem Terzi, Prof.
Contact
00905323776935
mustafcem@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.